EXECUTIVE ENGAGEMENTS
POOL
6342
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1013
Interactions with Platform & by Email
PARTICIPANTS
192
Unique # Participated
VALIDATIONS
41
Responses Validated*
COMPANIES
46
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
321
PAGES
397
EDITION
9
PRICE
USD 5450
CODE
MCP16773
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Sexually Transmitted Diseases (STDs) Drug estimated at US$47.7 Billion in the year 2020, is projected to reach a revised size of US$91.7 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Chlamydia, one of the segments analyzed in the report, is projected to record a 10% CAGR and reach US$14.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gonorrhea segment is readjusted to a revised 8% CAGR for the next 7-year period.
The Sexually Transmitted Diseases (STDs) Drug market in the U.S. is estimated at US$12.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$19.3 Billion by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 8.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.
In the global Syphilis segment, USA, Canada, Japan, China and Europe will drive the 7.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$699.9 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$13.2 Billion by the year 2027, while Latin America will expand at a 9.1% CAGR through the analysis period.
SELECT PLAYERS
AbbVie, Inc.; Bayer Healthcare AG; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche AG; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Johnson & Johnson; Merck & Co., Inc.; Pfizer, Inc.
SEGMENTS
» Disease Type (Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS, Other Disease Types) » Sales Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Sales Channels) » Therapy (Antibiotics, Antiviral / Antiretrovirals, Vaccines, Other Therapies)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Chlamydia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Chlamydia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Chlamydia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Gonorrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Gonorrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Gonorrhea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Syphilis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Syphilis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Syphilis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Genital herpes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Genital herpes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Genital herpes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for HPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for HPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for HPV by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for HIV/AIDS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for HIV/AIDS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for HIV/AIDS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Antiviral / Antiretrovirals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Antiviral / Antiretrovirals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Antiviral / Antiretrovirals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Sales Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Sales Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Sales Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Disease Type - Percentage Breakdown of Value Sales for Chlamydia, Gonorrhea, Syphilis, Genital herpes, HPV, HIV/AIDS and Other Disease Types for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Sexually Transmitted Diseases (STDs) Drug by Therapy - Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Therapy - Percentage Breakdown of Value Sales for Antibiotics, Antiviral / Antiretrovirals, Vaccines and Other Therapies for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Sexually Transmitted Diseases (STDs) Drug by Sales Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Other Sales Channels for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 46 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com